PASGHealthcareNano-Cap

Passage BIO, Inc. Insider Trading Activity

Every SEC Form 4 insider transaction reported for Passage BIO, Inc. (PASG), sourced directly from SEC EDGAR and updated as new filings are accepted.

Last updated:

Quick Answer

Are PASG insiders buying or selling?

Passage BIO, Inc. insiders reported 32 open-market buys ($53.7M) and 26 sells ($1.4M) across 58 Form 4 filings — a net buying position of $52.3M.

Source: SEC EDGAR Form 4

Key Statistics (as of Jun 29, 2026)

Total Form 4 filings
58
SEC EDGAR
Insider filers
22
Insider buys (32)
$53.7M
Insider sells (26)
$1.4M

Insider sentiment

Net buying

Net insider flow of $52.3M in net buying. 1 insider buy in the last 90 days.

Recent PASG insider transactions

DateInsiderRoleTypeSharesPriceValue
Jun 29, 2026Lynx1 Capital Management LP10% OwnerPurchase50.1K$4.12$206.1K
Jan 12, 2026William ChouPRESIDENT AND CEOSale4.1K$18.44$75.2K
Jan 12, 2026Kathleen BorthwickCFOSale2.1K$18.44$38.0K
Sep 16, 2025Lynx1 Capital Management LP10% OwnerPurchase32.0K$6.99$223.7K
Jul 24, 2025Lynx1 Capital Management LP10% OwnerPurchase128.8K$5.70$733.8K
Jun 26, 2025ORBIMED ADVISORS LLC10% OwnerSale583.7K$0.34$197.2K
Apr 24, 2025ORBIMED ADVISORS LLC10% OwnerSale235.6K$0.33$78.7K
Apr 17, 2025ORBIMED ADVISORS LLC10% OwnerSale149.1K$0.33$49.7K
Feb 12, 2025Kathleen BorthwickCFOSale3.2K$0.53$1.7K
Jan 14, 2025ORBIMED ADVISORS LLC10% OwnerSale223.2K$0.64$142.2K
Jan 8, 2025ORBIMED ADVISORS LLC10% OwnerSale147.0K$0.70$103.3K
Dec 31, 2024Lynx1 Capital Management LP10% OwnerPurchase373.6K$0.65$241.0K
Dec 26, 2024ORBIMED ADVISORS LLC10% OwnerSale230.3K$0.60$138.2K
Dec 11, 2024ORBIMED ADVISORS LLC10% OwnerSale62.3K$0.83$52.0K
Dec 7, 2024ORBIMED ADVISORS LLC10% OwnerSale97.1K$0.80$77.3K
Nov 27, 2024Lynx1 Capital Management LP10% OwnerPurchase456.4K$0.62$284.5K
Sep 23, 2024ORBIMED ADVISORS LLC10% OwnerSale39.3K$0.71$27.9K
Sep 18, 2024ORBIMED ADVISORS LLC10% OwnerSale200.1K$0.73$146.7K
Feb 14, 2024Kathleen BorthwickSVP, INTERIM CFOSale1.5K$0.97$1.4K
Feb 14, 2024Mark S FormanCHIEF MEDICAL OFFICERSale1.6K$0.97$1.6K
Jan 3, 2024Mark S FormanChief Medical OfficerSale15.8K$0.91$14.4K
Jan 3, 2024Kathleen BorthwickSVP, Interim CFOSale10.7K$0.91$9.7K
Jan 3, 2024Edgar B. CaleGC & Corporate SecretarySale15.8K$0.91$14.4K
Aug 1, 2023Simona KingChief Financial OfficerSale11.5K$0.88$10.1K
Jun 29, 2023ORBIMED ADVISORS LLC10% OwnerPurchase1.2M$0.84$1.0M

Showing the 25 most recent of 58 Form 4 filings for Passage BIO, Inc..

Most active PASG insiders

  • ORBIMED ADVISORS LLC17 filings
  • Lynx1 Capital Management LP5 filings
  • Kathleen Borthwick4 filings
  • Alexandros Fotopoulos3 filings
  • Bruce A Goldsmith3 filings

Ask anything about PASG insider activity

Use Trabud's AI agent to query Passage BIO, Inc.'s Form 4 history in plain English — "Show me PASG CEO purchases this year" or compare it against any other ticker.

Open the AI agent

PASG insider trading FAQ

Are Passage BIO, Inc. insiders buying or selling?

Across 58 SEC Form 4 filings, Passage BIO, Inc. (PASG) insiders reported 32 open-market purchases totaling $53.7M and 26 sales totaling $1.4M. That is a net buying position of $52.3M.

How many insiders trade PASG stock?

22 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for Passage BIO, Inc.. The most recent filing was accepted on Jun 29, 2026.

Where does Trabud get PASG insider trading data?

All PASG insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.

Looking for another company? Browse all tracked companies.

Related Content